<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Buchanan A</submitter><funding>NCI NIH HHS</funding><pagination>526-535</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8088447</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(4)</volume><pubmed_abstract>&lt;h4>Purpose&lt;/h4>The objective of this review was to assess the efficacy of non-pharmacological interventions on endometrial cancer (EC) survivors' QOL, and their use of patient-reported outcome measures (PROMs).&lt;h4>Methods&lt;/h4>We conducted a systematic review of randomized controlled trials (RCTs) of non-pharmacological interventions that assessed the impact of intervention on EC survivors' general and domain-specific QOL (i.e., physical, psychological, and social well-being) using PROMs.&lt;h4>Results&lt;/h4>Of the 3178 studies identified, 28 full-text articles were reviewed, and 10 were included in the review. Nine RCTs assessed at least one PROM as a primary outcome and six assessed a PROM as a secondary outcome, but few studies used validated PROMs. Significant improvements in general QOL were found in two studies, domain-specific QOL in three studies, and both general and domain-specific QOL in three studies; however, effect sizes ranged from small to large and no significant effects were found for social well-being and few were found for psychological well-being.&lt;h4>Conclusions&lt;/h4>Few non-pharmacological interventions for EC survivors targeted QOL, even though QOL was assessed as either a primary or secondary outcome of the RCT. Despite this, findings suggest that non-pharmacological interventions for EC survivors hold promise for improving general and domain-specific QOL. Use of validated PROMs would greatly enhance outcome reporting and facilitate comparisons across studies. More interventions are also needed that address social and psychological functioning in this population.&lt;h4>Implications for cancer survivors&lt;/h4>Our review highlights a need to (1) expand non-pharmacological RCTs for EC survivors, (2) increase the use of validated PROMs measuring QOL, and (3) address psychosocial domains of QOL when developing interventions for this population.</pubmed_abstract><journal>Journal of cancer survivorship : research and practice</journal><pubmed_title>Patient-reported outcomes of non-pharmacological interventions for endometrial cancer survivors: a systematic review.</pubmed_title><pmcid>PMC8088447</pmcid><funding_grant_id>P30 CA125123</funding_grant_id><pubmed_authors>Roddy M</pubmed_authors><pubmed_authors>Badr H</pubmed_authors><pubmed_authors>Buchanan A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Patient-reported outcomes of non-pharmacological interventions for endometrial cancer survivors: a systematic review.</name><description>&lt;h4>Purpose&lt;/h4>The objective of this review was to assess the efficacy of non-pharmacological interventions on endometrial cancer (EC) survivors' QOL, and their use of patient-reported outcome measures (PROMs).&lt;h4>Methods&lt;/h4>We conducted a systematic review of randomized controlled trials (RCTs) of non-pharmacological interventions that assessed the impact of intervention on EC survivors' general and domain-specific QOL (i.e., physical, psychological, and social well-being) using PROMs.&lt;h4>Results&lt;/h4>Of the 3178 studies identified, 28 full-text articles were reviewed, and 10 were included in the review. Nine RCTs assessed at least one PROM as a primary outcome and six assessed a PROM as a secondary outcome, but few studies used validated PROMs. Significant improvements in general QOL were found in two studies, domain-specific QOL in three studies, and both general and domain-specific QOL in three studies; however, effect sizes ranged from small to large and no significant effects were found for social well-being and few were found for psychological well-being.&lt;h4>Conclusions&lt;/h4>Few non-pharmacological interventions for EC survivors targeted QOL, even though QOL was assessed as either a primary or secondary outcome of the RCT. Despite this, findings suggest that non-pharmacological interventions for EC survivors hold promise for improving general and domain-specific QOL. Use of validated PROMs would greatly enhance outcome reporting and facilitate comparisons across studies. More interventions are also needed that address social and psychological functioning in this population.&lt;h4>Implications for cancer survivors&lt;/h4>Our review highlights a need to (1) expand non-pharmacological RCTs for EC survivors, (2) increase the use of validated PROMs measuring QOL, and (3) address psychosocial domains of QOL when developing interventions for this population.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Aug</publication><modification>2025-04-27T00:07:41.113Z</modification><creation>2025-04-06T17:47:08.345Z</creation></dates><accession>S-EPMC8088447</accession><cross_references><pubmed>33140266</pubmed><doi>10.1007/s11764-020-00946-z</doi></cross_references></HashMap>